BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33122657)

  • 1. Metabolomic profiles associated with a mouse model of antipsychotic-induced food intake and weight gain.
    Zapata RC; Rosenthal SB; Fisch K; Dao K; Jain M; Osborn O
    Sci Rep; 2020 Oct; 10(1):18581. PubMed ID: 33122657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear receptor 5A2 regulation of Agrp underlies olanzapine-induced hyperphagia.
    Zapata RC; Zhang D; Libster A; Porcu A; Montilla-Perez P; Nur A; Xu B; Zhang Z; Correa SM; Liu C; Telese F; Osborn O
    Mol Psychiatry; 2023 May; 28(5):1857-1867. PubMed ID: 36765131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities.
    Cooper GD; Pickavance LC; Wilding JP; Harrold JA; Halford JC; Goudie AJ
    J Psychopharmacol; 2007 Jun; 21(4):405-13. PubMed ID: 17050655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role of neuropeptide CART in hyperphagia and weight gain induced by olanzapine treatment in rats.
    Nakhate KT; Subhedar NK; Kokare DM
    Brain Res; 2018 Sep; 1695():45-52. PubMed ID: 29775565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for hypothalamic AMP-activated protein kinase in the mediation of hyperphagia and weight gain induced by chronic treatment with olanzapine in female rats.
    Sejima E; Yamauchi A; Nishioku T; Koga M; Nakagama K; Dohgu S; Futagami K; Kataoka Y
    Cell Mol Neurobiol; 2011 Oct; 31(7):985-9. PubMed ID: 21681559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling of energy metabolism in olanzapine-induced weight gain in rats and its prevention by the CB1-antagonist AVE1625.
    Liebig M; Gossel M; Pratt J; Black M; Haschke G; Elvert R; Juretschke HP; Neumann-Haefelin C; Kramer W; Herling AW
    Obesity (Silver Spring); 2010 Oct; 18(10):1952-8. PubMed ID: 20168311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine activates hepatic mammalian target of rapamycin: new mechanistic insight into metabolic dysregulation with atypical antipsychotic drugs.
    Schmidt RH; Jokinen JD; Massey VL; Falkner KC; Shi X; Yin X; Zhang X; Beier JI; Arteel GE
    J Pharmacol Exp Ther; 2013 Oct; 347(1):126-35. PubMed ID: 23926289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamic ghrelin signalling mediates olanzapine-induced hyperphagia and weight gain in female rats.
    Zhang Q; He M; Deng C; Wang H; Lian J; Huang XF
    Int J Neuropsychopharmacol; 2014 May; 17(5):807-18. PubMed ID: 24468236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phenotypic Caenorhabditis elegans screen identifies a selective suppressor of antipsychotic-induced hyperphagia.
    Perez-Gomez A; Carretero M; Weber N; Peterka V; To A; Titova V; Solis G; Osborn O; Petrascheck M
    Nat Commun; 2018 Dec; 9(1):5272. PubMed ID: 30532051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zonisamide prevents olanzapine-associated hyperphagia, weight gain, and elevated blood glucose in rats.
    Wallingford NM; Sinnayah P; Bymaster FP; Gadde KM; Krishnan RK; McKinney AA; Landbloom RP; Tollefson GD; Cowley MA
    Neuropsychopharmacology; 2008 Nov; 33(12):2922-33. PubMed ID: 18322467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Synthetic Interfering Peptide Tat-3L4F Attenuates Olanzapine-Induced Weight Gain Through Disrupting Crosstalk Between Serotonin Receptor 2C and Protein Phosphatase and Tensin Homolog in Rats.
    Wang Y; Wang D; Chen Y; Fang X; Yu L; Zhang C
    Int J Neuropsychopharmacol; 2020 Nov; 23(8):481-490. PubMed ID: 32710540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic histamine H1 receptor-AMPK signaling time-dependently mediates olanzapine-induced hyperphagia and weight gain in female rats.
    He M; Zhang Q; Deng C; Wang H; Lian J; Huang XF
    Psychoneuroendocrinology; 2014 Apr; 42():153-64. PubMed ID: 24636512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The atypical antipsychotic risperidone targets hypothalamic melanocortin 4 receptors to cause weight gain.
    Li L; Yoo ES; Li X; Wyler SC; Chen X; Wan R; Arnold AG; Birnbaum SG; Jia L; Sohn JW; Liu C
    J Exp Med; 2021 Jul; 218(7):. PubMed ID: 33978701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C.
    Lord CC; Wyler SC; Wan R; Castorena CM; Ahmed N; Mathew D; Lee S; Liu C; Elmquist JK
    J Clin Invest; 2017 Sep; 127(9):3402-3406. PubMed ID: 28805659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo pharmacological evaluations of novel olanzapine analogues in rats: a potential new avenue for the treatment of schizophrenia.
    Jafari S; Huang XF; Andrews JL; Fernandez-Enright F
    PLoS One; 2013; 8(12):e80979. PubMed ID: 24349027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain.
    Cooper GD; Harrold JA; Halford JC; Goudie AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):428-36. PubMed ID: 17933447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A low TSH profile predicts olanzapine-induced weight gain and relief by adjunctive topiramate in healthy male volunteers.
    Evers SS; van Vliet A; van Vugt B; Scheurink AJ; van Dijk G
    Psychoneuroendocrinology; 2016 Apr; 66():101-10. PubMed ID: 26802597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of hypothalamic AMPK on serine(485/491) related to sustained weight loss by alpha-lipoic acid in mice treated with olanzapine.
    Kim H; Park M; Lee SK; Jeong J; Namkoong K; Cho HS; Park JY; Lee BI; Kim E
    Psychopharmacology (Berl); 2014 Oct; 231(20):4059-69. PubMed ID: 24733236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two models for weight gain and hyperphagia as side effects of atypical antipsychotics in male rats: validation with olanzapine and ziprasidone.
    Shobo M; Yamada H; Mihara T; Kondo Y; Irie M; Harada K; Ni K; Matsuoka N; Kayama Y
    Behav Brain Res; 2011 Jan; 216(2):561-8. PubMed ID: 20816897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ziprasidone and aripiprazole attenuate olanzapine-induced hyperphagia in rats.
    Snigdha S; Thumbi C; Reynolds GP; Neill JC
    J Psychopharmacol; 2008 Jul; 22(5):567-71. PubMed ID: 18208914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.